- Home
- IMMP vs RLTY Comparison
IMMP vs RLTY Comparison
Compare IMMP & RLTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- RLTY
- Stock Information
- Founded
- IMMP 1987
- RLTY 2022
- Country
- IMMP Australia
- RLTY United States
- Employees
- IMMP N/A
- RLTY N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- RLTY Investment Managers
- Sector
- IMMP Health Care
- RLTY Finance
- Exchange
- IMMP Nasdaq
- RLTY Nasdaq
- Market Cap
- IMMP 221.2M
- RLTY 251.8M
- IPO Year
- IMMP N/A
- RLTY N/A
- Fundamental
- Price
- IMMP $1.72
- RLTY $15.49
- Analyst Decision
- IMMP Buy
- RLTY
- Analyst Count
- IMMP 1
- RLTY 0
- Target Price
- IMMP $7.00
- RLTY N/A
- AVG Volume (30 Days)
- IMMP 98.8K
- RLTY 86.7K
- Earning Date
- IMMP 02-27-2025
- RLTY 01-01-0001
- Dividend Yield
- IMMP N/A
- RLTY 9.35%
- EPS Growth
- IMMP N/A
- RLTY N/A
- EPS
- IMMP N/A
- RLTY N/A
- Revenue
- IMMP $3,019,249.00
- RLTY N/A
- Revenue This Year
- IMMP $50.37
- RLTY N/A
- Revenue Next Year
- IMMP N/A
- RLTY N/A
- P/E Ratio
- IMMP N/A
- RLTY N/A
- Revenue Growth
- IMMP 24.11
- RLTY N/A
- 52 Week Low
- IMMP $1.32
- RLTY $11.38
- 52 Week High
- IMMP $2.72
- RLTY $14.60
- Technical
- Relative Strength Index (RSI)
- IMMP 50.07
- RLTY 61.96
- Support Level
- IMMP $1.53
- RLTY $15.00
- Resistance Level
- IMMP $1.71
- RLTY $15.49
- Average True Range (ATR)
- IMMP 0.07
- RLTY 0.23
- MACD
- IMMP 0.01
- RLTY 0.03
- Stochastic Oscillator
- IMMP 72.41
- RLTY 92.31
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About RLTY Cohen & Steers Real Estate Opportunities and Income Fund of Beneficial Interest
Cohen & Steers Real Estate Opportunities and Income Fund is an organized, non-diversified, closed-end management investment company. The Fund's primary investment objective is high current income. The Fund's secondary investment objective is capital appreciation.